Third Arc Bio
4 known investors
Third Arc Bio develops breakthrough treatments in oncology and immunology through advanced biologics engineering. The company is led by a team with a track record of 35+ drug approvals.
BiotechMedical Devices
Investors · 4
In the news
- Third Arc Bio Announces $52M Series A Extension to Expand Oncology and Immunology & Inflammation Portfoliofinance.yahoo.com · 2026
- Montgomery County's Third Arc Bio raises another $52M led by top Silicon Valley VC firm - Philadelphia Business Journalbizjournals.com · 2026
- Third Arc Bio raises USD 52m in Series A for multi-function antibodies - AllSciallsci.com · 2026
- Third Arc Bio - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2024
- Third Arc Bio - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2024
- Third Arc Bio Launches with Oversubscribed $165 Million Series A Financing to Deliver Superior Biologics for Solid Tumors and Inflammatory & Immunology (I&I) Diseasesprnewswire.com · 2024